News about Medicine

Viser 97 til 120 af 169 dokumenter.

Innovative phage therapy project to combat "flesh-eating disease"

In a stride towards combating the rising global threat of Necrotizing Soft Tissue Infections, also known as the “flesh-eating disease”, the Leo Foundation has granted DKK 3,988,469 to a new innovative phage therapy…

Half of million Danes have it – now, researchers are chasing risk genes

Researchers have discovered new migraine genes which contain new and more accurate information about the condition of the individual patient. This may lead to more targeted treatment.

Seminar on Automated Genotyping

Seminar Details: Date: Thursday, October 26 Time 12:45-14:00 (start 13:00) Location: Dam Auditorium, Panum, Blegdamsvej 3b, 2200 Copenhagen N Speakers: Daniel Gercke, Inside Account Specialist - Europe David…

Improving Openness in Animal Research in Denmark

About this event For more information and registration, please go to the event web page. Date and time Wed, 8 Nov 2023 12:00 - 16:00 CET Location The Adolf Hannover Auditorium Faculty of Health and Medical Sciences…

Special issue on Sustainable Pharmacy in Eur J Pharm Sci – the call for papers is now open until October 2023

One of Nordic POP main priorities of focus in the past years was sustainable pharmaceutical research. together with AI and data riven pharmaceutical research, it was a main topic of 2021 Annual Meeting held by Uppsala…

Do No Harm - The Art of Reproducible Experimental Surgery in Rodents, and Why it Matters to You

A series of seminars where we aim to disseminate the knowledge of our talented team, and help you improve your setups, and obtain better data! For the first seminar, Thomas Svava Nielsen will give a talk titled “Do No…

Follow-up on the refurbishment of breeding unit 10-4 in the Panum Building

This letter provides an update on the upcoming renovation as well as a status on the comprehensive plan for the development of the department with topics i.e. management, finances, needs and services as well as the…

Bacteria like cholera may be crucial in the development of new antibiotics

Bacteria like the cholera bacteria move around in the body through rotations from a hairy appendage on the bacteria.

Bacteria like cholera may be crucial in the development of new antibiotics

Bacteria like the cholera bacteria move around in the body through rotations from a hairy appendage on the bacteria.

Giant study finds 694 new potentially harmful drug interactions

Data analysis of more than one million Danish inpatients identifies new drug interactions that are associated with mortality, hospital readmission or longer hospital stays.

Giant study finds 694 new potentially harmful drug interactions

Data analysis of more than one million Danish inpatients identifies new drug interactions that are associated with mortality, hospital readmission or longer hospital stays.

Oldest known molecule surprises researchers. It could lead to new important treatments

Researchers have previously believed that the ribosome, one of the body's most crucial molecular machines, was merely a helper when creating new cells. However, recent research reveals that the ribosome has far greater…

Oldest known molecule surprises researchers. It could lead to new important treatments

Researchers have previously believed that the ribosome, one of the body's most crucial molecular machines, was merely a helper when creating new cells. However, recent research reveals that the ribosome has far greater…

Quarantine system update

The quarantine from unit 16.4 to the Biocenter has been repealed, which means that animals and personnel can now move freely between these two units without quarantine restrictions. The quarantine restriction between…

Maintenance work at Panum

The service water will be closed on Thursday, August 17th in building 10 at Panum between 11:30 and 15:00. Sorry for any inconveniences.

NNF Challenge Programme grant of DKK 60 awarded to Professor Nikos Hatzakis

The Novo Nordisk Foundation has awarded a Challenge Programme grant of DKK 60 million to Professor Nikos Hatzakis for realising the drugs of the future.

Refurbishment of breeding unit 10-4 in the Panum Building

AEM is in collaboration with Campus Service (CAS) planning a much needed renovation of the breeding unit at 10-4 in the Panum Building which will commence April 2024. Prior to that the unit needs to be vacated. AEM will…

Thousands suffer from tabooed disease. New method makes it easier to identify the right treatment

More than 10 urgent visits to the bathroom a day due to diarrhoea can make it virtually impossible to lead a normal life. But new research can help doctors diagnose bile acid diarrhoea and find the right treatment.

Michael Ploug receives research grant to study the breakdown of fat in the smallest blood vessels

BRIC/Finsen Group Leader, Michael Ploug, and his Network Receives a Research Grant to Study the breakdown of fat in the smallest blood vessels.

Need help to quit smoking? Known drug might help reduce nicotine cravings

A drug that was originally developed to treat diabetes and severe overweight might also help people with nicotine dependence, concludes new research from the University of Copenhagen.

PartoMa at IMNHC: The injustice of unfit clinical guidelines in women’s and children’s health

On Wednesday, May 10th, the PartoMa team will host a thematic session at IMNHC titled "The Missing Link between Clinical Guidelines and Clinical Realities: Aligning Together." The session will be moderated by Thomas van…

CBMR secures five-year funding extension from Novo Nordisk Foundation

Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation.

The University of Copenhagen invests in the development of medicines from health-promoting gut bacteria

The University of Copenhagen is the first Danish university to invest in a company based on its own research in a unique collaboration with a venture fund. In April 2023, the spinout GutCRINE ApS received initial fundin…

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.